Arterial Hypertension as a Risk Comorbidity Associated with COVID-19 Pathology
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), is an ongoing global public health challenge. Current clinical data suggest that, in COVID-19 patients, arterial hypertension (AH) is one of the most common cardiovascul...
Main Authors: | Alexander Kamyshnyi, Inna Krynytska, Victoriya Matskevych, Mariya Marushchak, Oleh Lushchak |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | International Journal of Hypertension |
Online Access: | http://dx.doi.org/10.1155/2020/8019360 |
Similar Items
-
Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential
by: Olexandr Kamyshnyi, et al.
Published: (2021-12-01) -
Diagnostic value of a complete blood count in type 2 diabetes mellitus and comorbidities
by: Uliana HEVKO, et al.
Published: (2020-12-01) -
The Indices of Nitric Oxide System in Rats with Carrageenan-Induced Enterocolitis Combined with Diabetes Mellitus
by: Krynytska Inna, et al.
Published: (2018-09-01) -
The effect of immunoregulatory bacteria on the transcriptional activity of Foxp3 and RORyt genes in the gut-associated lymphoid tissue with Salmonella-induced inflammation in the presence of vancomycin and Ваcteroides fragilis
by: Yuliia Bukina, et al.
Published: (2020-05-01) -
DOES COMORBID OBESITY OR CHRONIC PANCREATITIS INFLUENCE THE CHOICE AND EFFECTIVENESS OF GLUCOSE-LOWERING THERAPY IN TYPE 2 DIABETIC PATIENTS?
by: Mariya MARUSHCHAK, et al.
Published: (2021-03-01)